Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-15-001619
Filing Date
2015-03-13
Accepted
2015-03-12 18:05:20
Documents
3
Effectiveness Date
2015-03-13

Document Format Files

Seq Description Document Type Size
1 DEFA14A lgnd-defa14a_20150415.htm DEFA14A 19915
2 GRAPHIC g201503121800018514448.jpg GRAPHIC 256648
3 GRAPHIC g201503121800017734447.jpg GRAPHIC 311381
  Complete submission text file 0001564590-15-001619.txt   803909
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33093 | Film No.: 15697072
SIC: 2834 Pharmaceutical Preparations